1 / 34

HCAI TECHNOLOGY INNOVATION PROGRAMME

A programme aimed at speeding up the development and adoption of new medical device and cleaning technologies to combat Healthcare Associated Infections (HCAIs). The programme focuses on technologies that add clinical value, increase value per NHS pound spent, and promote swifter development and adoption rates.

Download Presentation

HCAI TECHNOLOGY INNOVATION PROGRAMME

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. HCAI TECHNOLOGY INNOVATION PROGRAMME Paul Cryer Programme Manager Department of Health

  2. HCAI Technology Innovation Programme Aim • To speed up the development and adoption of new and novel medical device and/or cleaning related technologies to further help combat HCAIs Outcomes • Technology that the NHS needs • Products that add more clinical value at the front-line • More value per NHS £ spent on HCAI related technologies • Swifter development and adoption rates • A broader understanding of the evidence by the NHS and industry

  3. www.clean-safe-care.nhs.uk - (technologies tab)

  4. HCAI TECHNOLOGY INNOVATIONPROGRAMMEKEY STRANDS • The Rapid Review Panel ++ • NHS Smart Ideas Programmes • Design Bugs Out with the Design Council • Smart Solutions from SMEs • Product Surgeries for Innovators • The Science of Cleaning • Local Technology Reviews • Showcase Hospitals • Knowledge Networks • International HACI Technology Summit and Awards Programme • The Innovation Village

  5. Main Causes of Healthcare Associated Infections in England • Gastrointestinal – 22% • Urinary tract infection – 20% • Lower respiratory tract infection - 20% • Surgical site infection – 14% • Skin and soft tissue infections – 10% • Blood stream infections (bacteraemia) – 7%

  6. Often the case for development and/or adoption is based on the economic case for infection avoidance 2.39 The best estimate of treating healthcare associated infections therefore remains at least £1 billion, as quoted in our initial report in 2000 and our follow up in 2004. The cost of treating a healthcare associated infection varies, but …….estimates that each avoidable healthcare associated infection costs the NHS £4,300. The cost of treating a bloodstream infection such as MRSA is likely to be higher as length of stay is much longer.

  7. What works …… ? • hand hygiene • aseptic techniques • prudent antibiotic prescribing.

  8. How do we know what else works …….

  9. THE RAPID REVIEW PANEL “provide a prompt assessment of new and novel equipment, materials and other products that may be of value to the NHS in improving hospital infection control and reducing hospital acquired infection” We know if the basic science works because the Rapid Review Panel tells us …

  10. However knowing that a technology works is not enough …….

  11. …… we also need to know Does it work By how much does it work What’s the overall in-use value and what barriers can we take away to improve adoption

  12. HCAI TECHNOLOGY INNOVATION PROGRAMMESHOWCASE HOSPITALS • The Royal Wolverhampton Hospitals NHS Trust • Imperial College Healthcare NHS Trust • Calderdale and Huddersfield NHS Foundation Trust • Southampton University Hospitals NHS Trust • County Durham and Darlington NHS Foundation Trust • The Lewisham Hospital NHS Trust • Central Manchester University Hospitals NHS Foundation Trust • Mid Essex Hospital Services NHS Trust

  13. HCAI TECHNOLOGY INNOVATION PROGRAMME SHOWCASE HOSPITALS TECHNOLGY EVALUATIONS 2008/9 (RRP1) • Bardex IC – silver alloy coated hydrogel catheters • ChloraPrep – Enturia Insight Health Ltd • Bioquell Hydrogen Peroxide Vapour System • Convatec Flexiseal (faecal management system) • Hollister Zassi (bowel management system) • 3M CleanTrace ATP Testing • InteguSeal (microbial sealant) Kimberly-Clark (2009/10)

  14. www.clean-safe-care.nhs.uk - (technologies tab)

  15. 3M CleanTrace ATP Testing

  16. More recently ….. and unpublished as yet • Three surfaces tested (ceramic, laminate and stainless steel) • Three organisms used (C.diff, E. coli and MRSA) • In three parts with the top 10 micro fibre cloths used by the NHS • comparison of individual cloth performance • how large a surface could be cleaned by a single cloth • prolonged washing performance

  17. HCAI TECHNOLOGY INNOVATION PROGRAMME“LOCAL TECHNOLOGY REVEIWS” 2009/10SHOWCASE HOPSITALS • An infection control IT system (dashboard) into which other hospital information systems feed to consolidate data sets; • Rapid screening for C. Difficile to establish if patients get decolonisation treatment earlier than under current regimes; • The development of a hand hygiene educational DVD; • A citizens web site for local hospital information on infection advice and issues; • A review of infection issues associated with blood pressure cuffs – an informative study; • Service evaluation of a 2% chlorhexidine based infection resistant lines/site protector; • New hospital wide hand hygiene communications campaigns; • A new style dressings mat that provides multiple clean working surfaces. • Ultra sonics as a pre cleaning tool

  18. The environment as a key vector for infection….. the role of cleaning

  19. The role of environmental cleaning in the control of hospital-acquired infection S.J. Dancer* Department of Microbiology, Hairmyres Hospital, East Kilbride, UK KEYWORDS Acinetobacter; Environmental cleaning; C. difficile; Hospital-associated infection; Infection control; MRSA; Norovirus; VRE Summary Increasing numbers of hospital-acquired infections have generated much attention over the last decade. The public has linked the socalled ‘superbugs’ with their experience of dirty hospitals but the precise role of environmental cleaning in the control of these organisms remains unknown. Until cleaning becomes an evidence-based science, with established methods for assessment, the importance of a clean environment is likely to remain speculative. This review will examine the links between the hospital environment and various pathogens, including meticillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, norovirus, Clostridium difficile and acinetobacter. These organisms may be able to survive in healthcare environments but there is evidence to support their vulnerability to the cleaning process. Removal with, or without, disinfectants, appears to be associated with reduced infection rates for patients. Unfortunately, cleaning is often delivered as part of an overall infection control package in response to an outbreak and the importance of cleaning as a single intervention remains controversial. Recent work has shown that hand-touch sites are habitually contaminated by hospital pathogens, which are then delivered to patients on hands. It is possible that prioritising the cleaning of these sites might offer a useful adjunct to the current preoccupation with hand hygiene, since hand-touch sites comprise the less well-studied side of the hand-touch site equation. In addition, using proposed standards for hospital hygiene could provide further evidence that cleaning is a cost-effective intervention for controlling hospital-acquired infection. ª 2009 The Hospital Infection Society. Published by Elsevier Ltd. All rights reserved.

  20. Risks to patients from equipment and environment • High Risk - anything that enters a normally sterile body area (Sterilised) • Medium - anything in contact with intact mucous membrane (Sterilised, heat disinfected, chemical disinfected only if thermolabile) • Low - anything in contact with intact skin (Sterilised, heat or chemical disinfected, cleaned (socially) • Minimal - items not normally in contact with a patient (Cleaned; disinfected in exceptional circumstances) Peter HoffmanConsultant Clinical ScientistLaboratory of Healthcare-associated InfectionHealth Protection Agency

  21. The ability to kill a particular target microbe is a starting point for consideration but other factors need to be taken into account. Examples: • Inactivation by organic matter • Inability to penetrate lumps, clots, dried organic matter • Inadequate coverage (improper immersion, air bubble, poor coverage etc.) • Contact time, including time to drying Peter HoffmanConsultant Clinical ScientistLaboratory of Healthcare-associated InfectionHealth Protection Agency

  22. Key Issues • How are colonies sustained and hosted? • How do pathogens move from one host or location to another? • What turns colonisation into infection and who is most vulnerable? • How can pathogens be destroyed or deactivated? • Can the movement of pathogens be inhibited or prevented? Nigel Tomlinson.Principal Scientific AdvisorDH Estates and Facilities

  23. HCAI TECHNOLOGY INNOVATION PROGRAMMEENVIRONMENTAL SCIENCE …. for better targeted cleaning • Testing disinfectant products used in the NHS for efficacy against C. Difficile spores • Testing micro fibre – which work and how well? • Identifying the higher risk areas around the ward in terms of bacterial contamination and which surfaces attract which types of bacteria most. • How and which bacteria move around the ward area the most and what are the principle routes for transmission. • Knowing more about why people do and do not wash their hands before/after patient contact

  24. Ultra Sonics

  25. Hand Hygiene

  26. Our specially formulated CHG-based handwashing solutions for use in your Resurgent equipment. Contains skin conditioning agents.

  27. Design Bugs Out….. what’s it all about? “If things are designed to be cleaned more easily and made from materials that are more easily cleaned then they are likely to get cleaned better and be cleaner more often”

  28. National launch of prototypesApril 2009

  29. HCAI TECHNOLOGY INNOVATION PROGRAMMESME SMART SOLUTIONS

  30. Forward Look

  31. HCAI TECHNOLOGY INNOVATION PROGRAMME…. new ways of helping fight infection • New style hand cleansing systems • Affordable point of care rapid screening for MRSA in <30 minutes (and C.difficile) • Non toxic sporicidal cleansing agent – “life beyond chlorine” • Pathogen detection in the healthcare environment – alarms (visual, colour, noise etc) when bio load reaches a predefined limit e.g. • Disinfection of the entire patient bed area in one process giving the public confidence of “near infection free beds”. • More automated cleaning – especially for side rooms

  32. HCAI TECHNOLOGY INNOVATION PROGRAMME NHS “SMART IDEAS” PROGRAMME The way that C. difficile and MRSA bacteria spread are different – therefore as a general principle for C. Difficile we want to keep the bacteria in a known space and with MRSA we want to minimise person-person contact …. in the making! • Two styles of temporary isolation facility for patients with C.Difficile and MRSA • Portable hand wash facility • New style infection reducing toilet/commode • Air door

More Related